Zibo Qixiang Tengda Chemical Co., Ltd. Overview
Qixiang Tengda is China's leading independent C4 (four-carbon hydrocarbon) deep-processing chemical company, and is increasingly also a C3 (propane/propylene) producer. It converts refinery and cracker by-product streams into a flexible slate of solvents, rubber monomers, polymers and intermediates. Its anchor franchise is methyl ethyl ketone (MEK, butanone). The company describes its 260 kt/yr MEK capacity as the largest in China and in the world. Around this core sit maleic anhydride, butadiene made by butene oxidative dehydrogenation, butadiene rubber, nitrile latex, MMA, MTBE and tert-butanol. Since 2023 a 700 kt/yr propane dehydrogenation (PDH) unit has fed downstream propylene oxide (HPPO route) and acrylic acid capacity. A catalyst subsidiary, Qilu Keli, and a lower-margin international trading arm round out the group. After the 2022–2024 collapse of its former private parent (the Cedar/Xuesong group) and a court-led restructuring, the company has been controlled by Shandong Energy Group, one of China's largest provincial SOEs. Group revenue for FY2025 was CNY 23.8bn, and the company has been near breakeven-to-loss at the bottom of the chemical cycle.
Company's own description (FY2025 annual report, paraphrased)
Management describes the business as stable and organised around two pillars: chemical manufacturing and international trade. Its main products include MEK, maleic anhydride, propylene, rubber, butadiene, MMA, nitrile latex, tert-butanol, MTBE, propylene oxide, acrylic acid and a range of petroleum and chemical catalysts. Within manufacturing, management frames the company as a C4 specialist built on four "pivots": butene, isobutene, n-butane and isobutane. These streams pass through cracking, separation, conversion and refining, and then branch through oxidation, polymerisation and etherification routes. The resulting products are sold into solvents, synthetic rubber, artificial marble/unsaturated polyester, fuel additives and electronic chemicals. A C3 chain has been added along a propane → propylene → propylene oxide path, with acrylic acid and butyl acrylate as further derivatives. Management stresses that the plants are designed flexibly, so feedstock and product allocation can switch between chains as margins move.
Independent characterisation
Qixiang Tengda is a mid-cap, commodity-to-semi-specialty petrochemical processor with these characteristics:
Feedstock-spread economics: Earnings are driven by the spread between purchased C4/C3 feedstocks (mixed C4, n-butane, propane) and the realised prices of its products. Revenue is overwhelmingly product sales, with no meaningful subscription, licensing or service income. Catalysts sold by Qilu Keli are the closest thing to a technical-product business.
Mid-stream position: The company sits between the refiners and crackers that supply its C4/C3 streams (including Sinopec Qilu in the same Zibo industrial cluster, plus imported LPG/propane for PDH) and downstream converters. Those converters include coatings, adhesives, ink, synthetic leather, tyres, gloves, PMMA/acrylic sheet, polyurethane foam, unsaturated polyester resin and super-absorbent polymer producers.
Trade arm: The international trade segment adds roughly 35–37% of revenue at gross margins of about 2–3%. It inflates the top line, contributes little profit, and consumes working capital.
Customer types: The customers are industrial B2B buyers: domestic and overseas chemical converters, distributors and traders. No single-customer concentration is disclosed in the sources reviewed.
End-markets: These are coatings and inks, adhesives, synthetic leather, electronics cleaning, tyres and rubber goods, nitrile gloves, PMMA and optical/display materials, polyurethanes (furniture, autos), gasoline blending, and refinery/coal-chemical catalysts. Many are construction- and consumer-cyclical, and management explicitly cites property-linked demand weakness in FY2025.
Revenue model mix (FY2025)
| Revenue type | FY2025 revenue (CNY Mn) | Share of total | Gross margin | Source |
|---|---|---|---|---|
| Chemical manufacturing (product sales) | 14,694 | 61.8% | 4.74% | FY2025 AR via Lixinger |
| International trade | 8,840 | 37.2% | 2.13% | FY2025 AR via Lixinger |
| Other / other operating revenue | 236 | 1.0% | — | Derived residual (total less segments) |
| Services / subscription / licensing | 0 | 0% | — | Not a disclosed revenue line |
Strategy
Stated strategy themes (FY2025 AR and "Quality and Return" progress report, paraphrased)
-
Deepen the C4 chain and keep leadership in MEK and maleic anhydride. Achieve this through refined operations, technical optimisation and stable, long-cycle plant runs.
-
Optimise and extend the C3 chain (propane → propylene → PO; acrylic acid and butyl acrylate). Use process flexibility to switch between chains in response to margins.
-
"Stock optimisation" rather than greenfield expansion. Extend existing chains into higher-value fine chemicals, specialty chemicals and new materials (anhydrous TBA, aldehyde series, MBS latex, high-performance catalysts).
-
Innovation and technical revamps. The company ran 51 process revamp projects in FY2025. It uses a "targeted problem-solving" R&D model and partners with universities and institutes.
-
Catalysts as a profit engine. Push Qilu Keli toward import substitution and a scaled, intelligent and green operating model.
-
Globalisation. Use the Singapore, Switzerland and US hubs to take share during the window of overseas capacity exits, and strengthen international pricing power.
-
Parent synergy. Lean on Shandong Energy Group for lower financing costs, governance standards and internal resource coordination.
-
Shareholder returns and governance. Pursue stable cash dividends (suspended for FY2025 because of the loss), buybacks, better disclosure and ESG reporting.
Initiatives announced in the last 24 months
| Date | Initiative | Detail / target | Status |
|---|---|---|---|
| Apr 2025 | "Quality and Return Dual Improvement" action plan | Focus on core business, innovation, governance, investor communication and returns | Progress report published Apr 2026 |
| 2,025 | Anhydrous tert-butanol project | Higher-purity TBA for high-end customers | In mass production |
| 2,025 | Ether-cracking dual-route revamp | Flexibility on the isobutene / MTBE chain | In mass production |
| Aug 2025 | Qilu Keli 8 kt/yr high-performance catalytic materials | CNY 70M; import substitution and precious-metal thrifting | Commissioned; contributing in H1 2026 |
| 2025–2026 | Aldehyde-based specialty chemicals (kiloton) | New fine-chemical products | Commissioned |
| 2,025 | Large-particle MBS latex | PVC impact modifier | Completed |
| 2,025 | Maleic anhydride consumption-optimisation series | Lower raw-material and solvent use per ton; higher steam by-product value | Completed |
| FY2025 | 51 process technical revamps | Efficiency and quality improvement | Completed / ongoing |
| Oct 2025 | Governance reform | Supervisory board abolished; 18 governance policies revised | Completed |
| Apr 2026 | 2026 FX hedging programme | Up to USD 30M notional | Approved |
| Apr 2026 | 2026 credit facilities | Up to CNY 17bn in aggregate | Approved by the AGM |
| 2,026 | ESG reporting | FY2025 ESG report published Apr 2026 | Ongoing |
Cost programmes: No quantified group-wide cost-reduction target was disclosed. Management describes "lean production and refined management" and lower unit energy and material consumption in qualitative terms.
Medium-term financial targets and guidance
Not publicly disclosed. The company does not issue numeric revenue, margin or ROE targets. Its only forward-looking quantitative disclosures are statutory profit pre-announcements (for example, the H1 2026 net income range of CNY 110–121M).
Products & Services
Capacities are design capacities as disclosed. Where sources conflict, both figures are shown. Product-level pricing is commodity market-based, and no list pricing is disclosed.
C4 chain
| Product | Description & applications | Capacity / specs | Target customer | Status / year | Notes |
|---|---|---|---|---|---|
| Methyl ethyl ketone (MEK, butanone) — flagship | High-purity solvent with strong solvency and moderate volatility. Used in coatings, adhesives, tapes, synthetic leather, inks and electronic cleaning. Positioned as a lower-toxicity replacement for benzene-series solvents and as an alternative to acetone. | 260 kt/yr design (after the 80 kt expansion announced 2021). The company says this is the largest in China and globally. China capacity was about 880 kt/yr in 2024. | Coatings, adhesive and ink makers; exporters | Expansion announced 2021, completed by FY2024 | Company claimed about 70% domestic production/sales share (FY2024 AR). A secondary source (dcf-analysis) cites 46% as of Dec 2025. The discrepancy is likely definitional (capacity vs. sales share); the primary filing is preferred. |
| Butadiene | Monomer for synthetic rubbers (SBR, BR, NBR, CR), ABS/SBS resins, nylon-66 intermediates and THF | Uses butene oxidative dehydrogenation, which the company calls China's largest such process; it is not tied to ethylene-cracker scale. | Mainly captive use (BR, nitrile latex) | Operating | Integration hedge against cracker-sourced butadiene volatility |
| Butadiene rubber (BR / 顺丁橡胶) | Core compound for truck and passenger tyres | 110 kt/yr design (company statement, 2024) | Tyre makers | Operating | Management linked 2024–2025 demand to heavy-truck tyres and infrastructure |
| Nitrile latex (丁腈胶乳) | Base material for nitrile gloves and paper/textile coatings | Expansion of 200 kt/yr announced 2020 | Glove manufacturers | Operating | Exposed to the glove-industry cycle after the pandemic |
| Large-particle MBS latex | Impact-modifier latex for PVC | New project completed in FY2025 | PVC compounders | Commissioned 2025 | Upgrade under "stock optimisation" |
| Maleic anhydride (顺酐) | n-Butane oxidation route. Used in unsaturated polyester resin (artificial marble, FRP), fumaric/tartaric acid, lubricant additives, coatings, food/feed additives. | 200 kt/yr base plus a 200 kt/yr expansion announced 2021. A secondary source cites 150 kt/yr, and a 100 kt/yr unit was referenced in a 2024 maintenance notice. Total currently operating is not fully verified. | UPR, chemicals, food/feed | Operating | Management ran a "maleic indicator optimisation" programme in FY2025 to cut raw-material and solvent consumption |
| MTBE | Gasoline octane enhancer from isobutene etherification | — | Refiners, fuel blenders | Operating | Ether-cracking dual-route revamp completed in FY2025 |
| High-purity isobutene / tert-butanol (TBA), including anhydrous TBA | Isobutene for pharmaceutical intermediates and polymers; anhydrous TBA for specialty solvents and intermediates | Capacity not disclosed | Pharma and fine chemicals | Anhydrous TBA commissioned 2025 | Higher value-add extension |
| MMA (methyl methacrylate) | Monomer for PMMA (acrylic glass), coatings modifiers, display panels and battery encapsulation | 200 kt/yr (phase II completed Mar 2021) | PMMA, coatings, electronics | Operating | Faces heavy Chinese capacity additions |
| Isooctane | Clean gasoline blending component | Capacity not disclosed | Refiners | Operating | Listed in the FY2023/FY2024 product lists |
| Aldehyde-based specialty chemicals (醛基系列) | Kiloton-scale aldehyde specialty chemicals R&D-to-production project | Kiloton scale | Fine-chemical customers | Commissioned 2025–2026 | Cited as an H1 2026 profit contributor |
| Isononanol (INA) | Plasticiser alcohol | 200 kt/yr project (approved 2020) | Plasticiser makers | — | May have been deferred; not referenced in FY2025 AR |
C3 chain
| Product | Description & applications | Capacity / specs | Target customer | Status | Notes |
|---|---|---|---|---|---|
| Propylene (PDH) | Propane dehydrogenation to polymer/chemical-grade propylene, feeding PO and acrylic acid | 700 kt/yr | Captive plus merchant | Fully on stream by 2023 | Exposed to imported propane (LPG) cost |
| Propylene oxide (PO) | HPPO route (hydrogen peroxide direct oxidation), technology jointly developed by Evonik and thyssenkrupp; water is the only by-product. Used in polyether polyols for PU foam, coatings and electronic adhesives. | 300 kt/yr, with a 205 kt/yr high-concentration hydrogen peroxide plant | PU polyol makers | Ready for start-up in 2023; operating since | Lower energy and environmental burden than the chlorohydrin route |
| Acrylic acid | Intermediate for acrylate esters and SAP | 80 kt/yr | Ester and SAP producers | Operating (project 2023) | — |
| Butyl acrylate | Waterborne coatings, adhesives, lithium-battery separator coatings | 60 kt/yr | Coatings and adhesives | Operating | — |
Catalysts (Qilu Keli)
| Product family | Applications | Notes |
|---|---|---|
| Hydrocarbon steam-reforming (hydrogen production) catalysts | Refinery and chemical hydrogen plants | Long-established line |
| Sulfur-tolerant shift catalysts | Coal chemical and syngas | Core product |
| Sulfur-recovery (Claus) catalysts | Refinery and gas-plant environmental units | — |
| Hydrotreating / hydrogenation catalysts | Refining | — |
| Fine-chemical catalysts and other purification agents | Fine chemicals, environmental | — |
| 8 kt/yr high-performance catalytic new materials project | Raises in-house high-end catalyst supply; supports import substitution; R&D on precious-metal thrifting and lightweight synthesis | CNY 70M capex, approved Aug 2025, commissioned before H1 2026 |
International trade services
| Offering | Description | Hubs |
|---|---|---|
| Chemical and energy product trading | Export of own products plus third-party chemical and energy trading; full-chain coordination from raw material to sales | Singapore, Switzerland, USA, covering Southeast Asia, Europe, Latin America and Africa |
Financial Narrative
Basis: PRC GAAP (CAS) consolidated statements as standardized by S&P Global Market Intelligence (via StockAnalysis.com), cross-checked with company-reported headline figures. Revenue is "revenue as reported" (operating revenue plus other revenue). FY2024 net income reflects the FY2025 retrospective restatement for CSRC Accounting Guideline No. 5 (deferred tax on convertible bonds). The original FY2024 figure was CNY 31.68M; restated it is CNY 34.45M.
Income statement
FY2025 basic EPS of CNY -0.20 is company-reported (Securities Star summary of the FY2025 AR). The company-reported FY2025 gross margin is 3.21%; the S&P-standardized figure is 3.04%, the difference being the treatment of other revenue.
Margins (%)
Revenue CAGR FY2021–FY2025: -9.2% per year (computed). The 3-year CAGR (FY2022–FY2025) is -7.3%.
Dividends per share (CNY)
FY2022: CNY 1.6 per 10 shares (CNY 455M total). FY2023: CNY 0.7058 per 10 shares (CNY 200M). FY2024: a CNY 0.3 per 10 final (CNY 84.6M), plus an interim that brings total FY2024 cash dividends to CNY 254M, implying about CNY 0.09 per share in total (computed). FY2025: nil.
Quarterly cadence
Derived: Q1 2025 is backed out from the Q1 2026 YoY change (+4.91% revenue, -1,796.62% net income). Q2 and Q3 2025 come from S&P quarterly data and the 9M 2025 loss of about CNY -146M. Q4 2025 is company-reported (CNY 5.558bn revenue, CNY -429M net income). Q2 2026 equals H1 2026 (revenue CNY 15.630bn, net income CNY 116.4M) less Q1 2026. Q1 2026 revenue is +4.9% YoY.
Balance sheet
At 30 Jun 2026: total assets were CNY 23.70bn (-3.35% vs. YE2025) and parent equity was CNY 11.21bn (+1.23%). The convertible bond (about CNY 679M outstanding) was repaid in cash on 19 Aug 2026, after the balance-sheet date.
Cash flow
H1 2026 operating cash flow was CNY 843M (+0.3% YoY). TTM to Jun 2026 FCF was about CNY 1.34bn (S&P).
Ratios
A secondary source cites annual interest expense of about CNY 239M. Against FY2024 EBIT of CNY 245M that implies coverage of about 1.0x, and against FY2025 EBIT coverage is negative. On an EBITDA basis, FY2025 coverage is about 4.8x. Financial expenses were CNY 65M in Q1 2026 alone. A media summary of the FY2025 AR put interest-bearing debt at 43.3% of total assets.
Commentary on trends, inflections and drivers
Revenue. Revenue peaked at CNY 34.9bn in FY2021, helped by a post-pandemic commodity spike and a large trading book. It then declined for four consecutive years to CNY 23.8bn in FY2025. Two forces drove the decline. First, prices for the main products fell as China's 2023–2025 wave of petrochemical capacity, which management calls one of the historical peaks of capacity release, met slowing property-linked demand. Second, the domestic supply-chain trading book was deliberately reshaped into "international trade". The decline is price-led, not volume-led: management says plant loads were kept on long, stable runs in FY2025.
Margins. Gross margin compressed from 12.5% to 3.0% over the period. The chemical segment margin halved in FY2025 alone (8.8% to 4.7%). Two structural factors amplified the cyclical squeeze: the large new C3 asset base and the depreciation that came with it. D&A rose from CNY 1.05bn in FY2021 to a peak of CNY 1.79bn in FY2023 as the PDH, PO and MMA assets entered service. That fixed-cost step-up means the operating line now breaks even only at higher spreads than before.
Net income. The FY2025 loss of CNY -575M was well below a sell-side consensus of about CNY 887M profit, per Securities Star. It was driven almost entirely by operations: asset impairments were only CNY 38.5M pre-tax, reducing net income by CNY 32.8M. Q4 2025 alone lost CNY 429M on revenue down 19% YoY.
Inflection in 2026. Q1 2026 remained loss-making (CNY -92M) with a 4.8% gross margin. Q2 2026 then swung to an estimated CNY 208M profit on revenue of about CNY 9.7bn. Management attributed this to three factors: an energy-price shock that lifted product prices, overseas capacity closures creating supply-demand mismatches, and a surge of more than 50% in overseas trade. By mid-September 2026 management said product prices had retreated from their March–April highs, but spreads remained better than in Q4 2025.
Balance sheet. Net debt rose from CNY 4.65bn to about CNY 7.4bn over the capex cycle (cumulative FY2021–FY2023 capex of CNY 12.7bn). Debt has also shifted short: short-term debt including current maturities reached CNY 8.3bn by FY2025, against cash of CNY 3.2bn. The current ratio of 0.63x and working capital of CNY -4.0bn are the most important balance-sheet vulnerabilities. They are mitigated by SOE-parent support, including access to the Shandong Energy Group Finance Company, and a CNY 17bn credit-line authorisation for 2026.
Cash flow. With capex down to about CNY 0.6–0.75bn per year, the company has generated positive FCF since FY2024 despite accounting losses. OCF of about CNY 1.3bn comfortably exceeds maintenance capex, and the cash cost base was sufficient to retire the CNY 679M convertible on time in August 2026.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment
| Segment | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Chemical manufacturing revenue (CNY Mn) | 17,499 | 16,705 | 14,694 |
International trade / supply chain revenue (CNY Mn, FY2023 derived residual) | 8,896 | 8,110 | 8,840 |
Other revenue (CNY Mn) | 523 | 404 | 236 |
Total revenue (CNY Mn) | 26,918 | 25,219 | 23,770 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansSegment Margins & Growth (%) and Results by Segment
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Chemical gross margin (%) | 9.68 | 8.82 | 4.74 |
Chemical gross profit (CNY Mn) | 1,695 | 1,473 | 696 |
Chemical share of revenue (%) | 65.01 | 66.24 | 61.82 |
Chemical YoY revenue growth (%) | 0 | -4.5 | -12.0 |
Segment Margins & Growth (%) and Results by Segment (FY2024–FY2025)
| Metric | FY2024 | FY2025 |
|---|---|---|
Trade gross margin (%) | 2.77 | 2.13 |
Trade gross profit (CNY Mn) | 225 | 188 |
Trade share of revenue (%) | 32.16 | 37.19 |
Trade YoY revenue growth (%) | -8.8 | 9.0 |
Segment Margins & Growth (%)
| Metric | H1 2024 | H1 2025 |
|---|---|---|
Chemical revenue | 7,776 | 7,642 |
Chemical gross margin (%) | 7.15 | 6.19 |
Trade revenue | — | 4,306 |
Trade gross margin (%) | — | 1.55 |
Group Entities
| Entity | Ownership | Role |
|---|---|---|
Qingdao Siyuan Chemical Co., Ltd. | Wholly owned | Chemical manufacturing subsidiary (Qingdao) |
Qixiang Tengda (Hong Kong) Co., Ltd. | Wholly owned | Offshore holding / trade |
Zibo Tenghui Oil Chemical Co., Ltd. | Wholly owned | Oil/chemical processing |
Shandong Qilu Keli Chemical Research Institute Co., Ltd. | — | Catalysts |
Qixiang Huali New Materials Co., Ltd. | Wholly owned | New materials |
Granite Capital S.A. (Switzerland) | Subsidiary; goodwill CGU | International trading hub |
Zibo Qixiang Tengda Supply Chain Co., Ltd. | Wholly owned (per earlier reports) | Trading / supply chain |
Zibo Linzi Petrochemical Fuel Co., Ltd. | 100% (acquired 2020) | Feedstock / storage |
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (CNY Mn) | 34,892 | 29,810 | 26,918 | 25,219 | 23,770 |
Revenue growth YoY (%) | 41.34 | -14.56 | -9.70 | -6.31 | -5.75 |
Cost of revenue (CNY Mn) | 30,515 | 27,245 | 25,317 | 23,833 | 23,047 |
Gross profit (CNY Mn) | 4,377 | 2,565 | 1,602 | 1,386 | 723 |
SG&A (CNY Mn) | 561 | 636 | 460 | 428 | 417 |
R&D expense (CNY Mn) | 579 | 706 | 655 | 675 | 668 |
Operating income (CNY Mn, derived: GP less opex) | 3,110 | 1,108 | 451 | 245 | -372 |
EBITDA (CNY Mn, derived from S&P EV/EBITDA) | 4,151 | 2,324 | 2,237 | 1,976 | 1,158 |
Depreciation & amortization (CNY Mn) | 1,051 | 1,224 | 1,793 | 1,741 | 1,538 |
Net income attributable to parent (CNY Mn) | 2,393 | 634 | -384 | 34 | -575 |
Net income excl. non-recurring items (CNY Mn, company-reported) | 0 | 0 | -253 | 15 | -583 |
EPS basic (CNY, computed NI/weighted shares approx.) | 0.84 | 0.22 | -0.14 | 0.01 | -0.20 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 12.54 | 8.60 | 5.95 | 5.50 | 3.04 |
Operating margin (%) | 8.91 | 3.72 | 1.68 | 0.97 | -1.57 |
EBITDA margin (%) | 11.90 | 7.80 | 8.31 | 7.84 | 4.87 |
Net margin (%) | 6.86 | 2.13 | -1.43 | 0.14 | -2.42 |
R&D / revenue (%) | 1.66 | 2.37 | 2.43 | 2.68 | 2.81 |
Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Dividend per share (CNY, declared for the year) | 0.160 | 0.0706 | 0.090 | 0.000 |
Income Statement
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|
Revenue (CNY Mn) | 5,618 | 6,590 | 6,000 | 5,558 | 5,894 | 9,736 |
Net income attributable (CNY Mn) | 5 | 18 | -169 | -429 | -92 | 208 |
Balance Sheet and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (CNY Mn) | 26,071 | 29,001 | 26,780 | 25,361 | 24,524 |
Cash & equivalents (CNY Mn) | 2,603 | 2,609 | 3,111 | 2,901 | 3,188 |
Accounts receivable (CNY Mn) | 4,245 | 4,399 | 2,036 | 2,229 | 1,751 |
Inventory (CNY Mn) | 1,195 | 1,477 | 1,764 | 1,185 | 1,489 |
PP&E (CNY Mn) | 11,537 | 15,575 | 15,098 | 14,439 | 13,434 |
Short-term debt incl. current LTD (CNY Mn) | 4,296 | 5,387 | 6,369 | 7,362 | 8,314 |
Long-term debt (CNY Mn) | 2,951 | 3,351 | 3,106 | 2,997 | 2,295 |
Total debt incl. leases (CNY Mn) | 7,258 | 8,759 | 9,947 | 10,475 | 10,627 |
Net debt (CNY Mn) | 4,652 | 6,148 | 6,834 | 7,570 | 7,403 |
Total equity (CNY Mn) | 13,420 | 14,086 | 12,315 | 11,873 | 11,229 |
Equity attributable to parent (CNY Mn) | 12,790 | 13,488 | 11,801 | 11,661 | 11,071 |
Goodwill (CNY Mn) | 1,004 | 922 | 641 | 641 | 641 |
Other intangibles (CNY Mn) | 1,481 | 1,510 | 1,731 | 1,617 | 1,603 |
Working capital (CNY Mn) | -464 | -1,791 | -3,522 | -3,717 | -4,018 |
Book value per share (CNY) | 4.50 | 4.74 | 4.16 | 4.14 | 3.93 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (CNY Mn) | 2,040 | 1,460 | 661 | 1,352 | 1,303 |
Capital expenditure (CNY Mn) | 5,782 | 4,633 | 2,313 | 753 | 632 |
Free cash flow (CNY Mn) | -3,741 | -3,173 | -1,652 | 599 | 670 |
Dividends paid (CNY Mn) | 718 | 810 | 590 | 504 | 262 |
Share buybacks (CNY Mn) | 0 | 0 | 0 | 120 | 0 |
Net debt issued / (repaid) (CNY Mn) | 1,821 | 1,679 | 1,427 | 1,184 | 340 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE (%) | 21.09 | 4.35 | -3.47 | 0.39 | -4.82 |
ROA (%, S&P basis) | 8.32 | 2.52 | 1.01 | 0.59 | -0.93 |
ROIC (%) | 17.70 | 4.82 | 2.29 | 1.16 | -1.96 |
Current ratio (x) | 0.95 | 0.84 | 0.68 | 0.64 | 0.63 |
Quick ratio (x) | 0.73 | 0.66 | 0.47 | 0.50 | 0.47 |
Debt / equity (x) | 0.54 | 0.62 | 0.81 | 0.88 | 0.95 |
Net debt / EBITDA (x) | 1.12 | 2.65 | 3.06 | 3.83 | 6.40 |
Asset turnover (x) | 1.49 | 1.08 | 0.97 | 0.97 | 0.95 |
Inventory turnover (x) | 31.23 | 20.40 | 15.63 | 16.17 | 17.24 |
DSO (days, computed year-end) | 44.4 | 53.9 | 27.6 | 32.3 | 26.9 |
DIO (days, computed) | 11.7 | 17.9 | 23.4 | 22.6 | 21.2 |
DPO (days, computed year-end) | 33.6 | 49.5 | 27.4 | 22.5 | 25.4 |
Cash conversion cycle (days, computed) | 22.5 | 22.3 | 23.6 | 32.4 | 22.7 |
Geographic Revenue
| Item | Detail | Source |
|---|---|---|
Overseas trade growth | More than 50% YoY in H1 2026 | H1 2026 profit pre-announcement, 10 Jul 2026 |
Regional hubs | Singapore, Switzerland, USA, covering Southeast Asia, Europe, Latin America and Africa | FY2025 AR |
FX exposure | Mainly USD; FX hedging capped at USD 30M notional at any point for 2026 | FX derivatives notice, Apr 2026 |
Share Price and Market Valuation
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Year-end share price (CNY) | 9.93 | 6.66 | 5.12 | 5.00 | 4.88 |
Year-end market cap (CNY Mn) | 29,847 | 20,013 | 15,010 | 14,185 | 13,762 |
Valuation Multiples
| Multiple | Qixiang Tengda |
|---|---|
P/E (TTM) | Not meaningful (TTM loss) |
EV/EBITDA | 15.6x (FY2025: 18.7x) |
EV/Sales | 0.81x |
P/S | 0.54x |
P/B | 1.30x |
P/TBV | 1.63x |
P/FCF | 11.0x |
FCF yield | 9.1% |
Analyst Ratings & Targets
| Broker | Date | Rating | Target |
|---|---|---|---|
Changjiang Securities (Wei Kai, Hou Yanfei) | 15 Apr 2026 | Buy | Not stated |
Changjiang Securities | 11 Nov 2025 | Buy | Not stated |
Changjiang Securities | 9 May 2025 | Buy | Not stated |
Guotai Haitong | 23 Apr 2025 | Overweight | CNY 5.30 |
Dividends & Capital Returns and Returns & Leverage Ratios (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Total cash dividends declared (CNY Mn) | 455 | 200 | 254 | 0 |
Payout vs. net income attributable (%) | 72 | 0 | 737 | 0 |
Credit Ratings
| Agency | Rating | Outlook | Date |
|---|---|---|---|
China Lianhe Credit Rating (issuer and convertible) | AA | Stable | 2025 surveillance |
Moody's / S&P / Fitch | Not rated | — | — |
Bucket Details
| Bucket | Amount (CNY Mn) |
|---|---|
Short-term borrowings | 6,910 |
Current portion of long-term debt (incl. convertible due Aug 2026) | 1,404 |
Long-term debt (due after 2026) | 2,295 |
Leases | 18 |
Total debt | 10627 |
Analyst Conclusions
Management guidance
No numeric full-year guidance has been given. Qualitatively, management describes the industry in mid-September 2026 as being in a weak recovery. It expects price recovery as downstream restocking resumes and the maintenance season ends, and it will continue cost reduction and process optimisation to protect reasonable profitability. The Q3 2026 report is due by 31 Oct 2026.
Consensus expectations
A verified consensus is not available. The single active broker (Changjiang) rates the stock Buy. The previous consensus for FY2025 profit (about CNY 887M) proved far too high, so street numbers should be treated with caution.
Bull case
-
Operating leverage on a fixed asset base. Q2 2026 alone produced about CNY 208M of net income on about CNY 9.7bn of revenue. Annualising even half of that spread environment implies a return to positive earnings, and EV/EBITDA would compress quickly from 15.6x.
-
Structural share gain abroad. Overseas capacity exits and a working three-hub trading network (overseas trade up more than 50% in H1 2026) could make exports a durable outlet for China's #1 MEK producer.
-
De-risked balance sheet and capex holiday. Capex is down 89% from its FY2021 peak, FCF is positive (about CNY 1.3bn TTM), the convertible is repaid, and SOE backing exists. Deleveraging and a resumption of dividends are plausible in 2027.
Bear case
-
Chinese overcapacity is structural. MMA, PO, acrylics and butadiene face continuing new supply. FY2025's 3% gross margin may be closer to the new normal than FY2021's 12.5%.
-
Short-dated leverage. Net debt of CNY 7.4bn, a current ratio of 0.63x and net debt/EBITDA of 6.4x leave little cushion if the H1 2026 price spike fully reverses, as September commentary suggests is partly happening.
-
Governance and minority-holder alignment. A 53% SOE controller, related-party flows, pledged parent shares, low institutional ownership and repeated leadership reshuffles (chairman change in Sep 2026) may cap the valuation multiple regardless of the cycle.
Catalysts and monitorables (next 12 months)
-
Q3 2026 results (by 31 Oct 2026): whether Q2's profitability held as product prices eased.
-
MEK–butane, maleic anhydride–butane and PO–propane spreads.
-
Strategy statements from new Chairman Sun Qingtao and GM Liu Fuliang; the EGM to seat Luan Fusheng.
-
Overseas revenue share in the FY2026 annual report (expected Apr 2027).
-
FY2026 dividend decision, given CNY 4.46bn of distributable profit.
-
Net debt trajectory and short-term debt refinancing after the convertible repayment.
-
Policy implementation of capacity rationalisation ("anti-involution") in Chinese petrochemicals.
-
Any Shandong Energy asset-optimisation or synergy announcements (currently unconfirmed).
-
Safety and environmental performance at the Zibo complex.
Analyst verdict
Qixiang Tengda is a company with one genuinely advantaged franchise, MEK, attached to a larger portfolio of mid-scale commodity chains and a low-margin trading book. The FY2021–FY2023 investment cycle (PDH, HPPO PO, MMA, acrylics) roughly doubled the fixed-cost base just as China's petrochemical industry entered what management calls one of its largest capacity waves. The result was predictable: four years of falling revenue, gross margin compressed to about 3%, a CNY 575M loss in FY2025, and net debt/EBITDA above 6x.
The 2026 picture is better but not yet proven. H1 2026 showed the earnings torque of the asset base: net income of CNY 116M and a strong Q2 driven by an energy-price spike and overseas share gains. However, management itself frames the backdrop as a weak recovery, and product prices had already retreated from their spring highs by September. The Q2 2026 profit should therefore be treated as partly cyclical windfall rather than a new run-rate.
Two factors keep the balance of risks tolerable for patient capital. First, the company now generates real free cash flow: capex is a fraction of peak, FCF is about CNY 1.3bn TTM, and it retired its CNY 679M convertible in cash. Second, its SOE parent supplies credit and governance support that the former private owner could not. The negatives are equally clear: a short-dated debt stack, minority-shareholder alignment questions, and a fresh leadership transition whose strategic agenda is unknown.
On balance, at about 1.3x book and 0.8x EV/Sales the shares price in a slow recovery but not a structural one. We would characterise the stock as a cyclical "hold / accumulate on weakness" for investors with a view on Chinese chemical-capacity discipline. The key confirmations to watch are Q3–Q4 2026 margins, net-debt reduction and a resumption of dividends. Without these, the bear case of a permanently lower margin structure remains credible.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Since | Background | Age / born |
|---|---|---|---|---|
Sun Qingtao (孙清涛) | Chairman; Party Secretary; Chair of Strategy Committee; Nomination Committee member | Chairman since 29 Sep 2026; previously Director and GM | Career at the Yankuang/Yanzhou Coal group: Lunan Fertilizer, Ordos Energy Chemical, Xinjiang Coal Chemical (GM), Yankuang Coal Chemical Engineering (Executive Director/GM), Yulin Energy Chemical (Chairman). Also Deputy GM of SNE New Materials. Master of Engineering; professor-level senior engineer. | Born May 1972 (54) |
Liu Fuliang (刘付亮) | General Manager; Director | GM since 29 Sep 2026; previously Executive Deputy GM | Yankuang International Coking; Ordos Energy Chemical; Shaanxi Future Energy coal-to-liquids; Yankuang Yulin Fine Chemical (HSE section chief, production centre director). Director of Tianchen Qixiang. Bachelor's; senior engineer; registered safety engineer. | Born Dec 1981 (44) |
Huang Liang (黄亮) | Deputy General Manager | 29 Sep 2026 | Joined the company in 2011 as a technician, rising to plant manager; later head of Safety Supervision / Eco-environment at SNE New Materials. Postgraduate; engineer. | Born Dec 1985 (40) |
Wang Yanxin (王彦鑫) | Chief Financial Officer | In role since at least H1 2024 | — | — |
Jiang Nengcheng (姜能成) | Board Secretary; Director | Board Secretary by FY2025 AR; succeeded Su Chao | — | — |
Rong Fang (荣芳) | Head of Accounting | In role since at least H1 2024 | — | — |
“—” = not publicly disclosed.
Board of Directors
| Name | Role | Independence | Notes |
|---|---|---|---|
Sun Qingtao | Chairman | Executive / shareholder-affiliated (SNE New Materials) | — |
Liu Fuliang | Director, GM | Executive | Strategy Committee member |
Zhu Hui (朱辉) | Non-independent director | — | Elected Jun 2026 |
Jiang Nengcheng | Director, Board Secretary | Executive | — |
Sun Wenli (孙文丽) | Employee-representative director | Employee director | Born Feb 1976. Party Discipline Secretary, Deputy Party Secretary and union chair. Formerly at Shandong Donghua Cement (Zibo Mining group). FY2025 pay about CNY 0.52M (Lixinger). |
Wang Ming (王鸣) | Independent director | Independent | Chair of Nomination Committee; Strategy Committee member |
Huang Yede (黄业德) | Independent director | Independent; accounting expert | — |
Fu Xu (付旭) | Independent director | Independent | Strategy Committee member; joined Jun 2026 |
Luan Fusheng (栾馥升) | Nominee (pending EGM) | Shareholder-affiliated | Born Mar 1986. Deputy Chief Economist and head of Operations Management at SNE New Materials. Fills the seat vacated by Li Qingwen. |
Li Qingwen (李庆文) | Former Chairman | — | Resigned for "work adjustment" (late Sep 2026); held no shares |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
29 Sep 2026 | Li Qingwen resigned as Chairman and Director; Sun Qingtao elected Chairman; Liu Fuliang appointed GM; Huang Liang appointed Deputy GM; Luan Fusheng nominated as director | Parent-driven reshuffle, described as a "work adjustment" |
Jun 2026 | Seventh board elected; Li Qingwen re-elected Chairman; Fu Xu joined as independent director | Regular three-year renewal |
Oct 2025 | Supervisory board abolished; employee-representative director seat added | New Company Law compliance |
2024–2025 | Board Secretary changed from Su Chao to Jiang Nengcheng | — |
2023–2025 | Founder Che Chengju moved from GM to non-executive status; Sun Qingtao became GM | — |
Apr 2023 | Director Chen Hui (Cedar appointee) unreachable | Legacy Cedar governance breakdown |
Major Shareholders
| Rank | Holder | Type | Stake | Shares |
|---|---|---|---|---|
| 1 | Shandong Energy Group New Materials Co., Ltd. | State-owned legal person | 53.18% | 1,511,964,163 |
| 2 | Che Chengju (founder) | Individual | 4.30% | 122,120,811 |
| 3 | Chang'an Trust – Qixiang Tengda Employee Stock Ownership Plan No. 1 | ESOP trust | 2.65% | 75,386,218 |
| 4 | Hong Kong Securities Clearing (Northbound Stock Connect) | Foreign legal person | 0.79% | 22,449,583 |
| 5 | Mei Jingming | Individual (margin account) | 0.50% | 14,164,905 |
| 6 | Yang Cuilan | Individual | 0.46% | 13,186,200 |
| 7 | Wang Hairong | Individual (margin account) | 0.31% | 8,900,000 |
| 8 | Song Yilong | Individual | 0.23% | 6,525,340 |
| 9 | Sun Tao | Individual | 0.22% | 6,250,000 |
| 10 | Cedar (Xuesong) Industrial Group | Private legal person | 0.21% | 6,109,040 |
Competitive Landscape
Competitors by Segment
| Segment / product | Named competitors | Relative positioning |
|---|---|---|
MEK | ExxonMobil; Shell; Sasol; Maruzen Petrochemical (Japan); Idemitsu Kosan (Japan); Formosa Plastics (Taiwan); PetroChina refinery MEK units; Sinopec-affiliated units | Company claims the #1 global capacity (260 kt/yr) and about 70% of domestic production and sales. China capacity is about 880 kt/yr in total, so other Chinese producers are smaller. |
Maleic anhydride | Other n-butane-route Chinese producers (Shandong and Jiangsu clusters); Huntsman (global); Lanxess (benzene route) | — |
Butadiene / BR | Sinopec; PetroChina (cracker-based butadiene and BR); private refiners | Company differentiated by its non-cracker butene-ODH route; much smaller BR scale than the majors |
MMA | Wanhua Chemical; Mitsubishi Chemical (Lucite); Röhm; several new Chinese C4/ACH-route entrants | Mid-scale; under heavy price pressure from new capacity |
PDH / propylene | Oriental Energy (Donghua Energy); Satellite Chemical; Jinneng Science & Technology; Wanhua Chemical | 700 kt/yr is mid-sized versus leading PDH operators |
Propylene oxide | Wanhua Chemical; Sinopec (SM/PO); Satellite / Jiangsu-based HPPO plants; Dow; LyondellBasell | 300 kt/yr HPPO is competitive on technology, but the market is oversupplied |
Acrylic acid / butyl acrylate | Satellite Chemical; Wanhua Chemical; BASF-YPC | Small scale (80/60 kt/yr) |
Catalysts (Qilu Keli) | Sinopec Catalyst Co.; Johnson Matthey; Haldor Topsoe (Topsoe); Clariant | Niche domestic supplier in shift, sulfur-recovery and hydrogen catalysts |
Trading | Chinese and global chemical traders | Commodity-like; low margin |
Competitor Detail
| Metric | Qixiang Tengda (FY2025) |
|---|---|
Revenue | CNY 23.8bn |
Revenue growth | -5.8% |
Gross margin | 3.0–3.2% |
Net margin | -2.4% |
R&D intensity | 2.8% |



